MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 7 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q3 2026, worth $14.2M in total; no superinvestor holds it.
Holders of 5% or more of MAIA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of MAIA Biotechnology, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FGMK Business Holdings, LLC | 13G | 9.99%2.89M shares | New | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Vitoc Vlad | 13D/A | 9.66%3.85M shares | – | Feb 14, 20233 filings | Dec 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on MAIA Biotechnology, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:47 AM ET | Solas Capital Management, LLCand 1 other | 13G/A | 4.90%3.03M shares | −2.20 ppfrom 7.10%Below 5% | Jun 30, 2026 | SEC |
| May 15, 202611:06 AM ET | Solas Capital Management, LLCand 1 other | 13G | 7.10%4.30M shares | New | Mar 31, 2026 | SEC |
| Dec 4, 20254:05 PM ET | Vitoc Vlad | 13D/A | 9.66%3.85M shares | – | Nov 21, 2025 | SEC |
| Mar 3, 20255:28 PM ET | FGMK Business Holdings, LLCand 1 other | 13G | 9.99%2.89M shares | New | Sep 14, 2024 | SEC |
| Feb 14, 20255:27 PM ET | Gryaznov Sergei | 13G/A | 4.08%1.14M shares | –Below 5% | Dec 31, 2023 | SEC |
| Oct 25, 2024 | Smith Stan | 13D/AOld format | – | – | – | SEC |
| Oct 25, 2024 | Louie Ngar Yee | 13DOld format | – | – | – | SEC |
| Oct 25, 2024 | Vitoc Vlad | 13DOld format | – | – | – | SEC |
| Feb 14, 2023 | Louie Ngar Yee | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Gryaznov Sergei | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Vitoc Vlad | 13GOld format | – | New | – | SEC |
| Aug 10, 2022 | Smith Stan | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell MAIA Biotechnology, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jan 19, 20249:00 PM ET | Obrocea MihailFormer director | 26.1K | $33.4K | Jan 19, 2024 | Fidelity Brokerage Services LLC | SEC |